Furthermore, the combination of xCT inhibitors with the traditional anticancer therapeutics, chemotherapy, and radiotherapy, but also with targeted therapy and immunotherapy can effectively suppress tumor growth and overcome drug resistance through induction of ferroptosis in numerous cancers [55, 59, 65]. Here, SLC7A11 is linked to cancer.